GlobeNewswire

Systemic Exposure in Patients with Moderate CKD With Once-Daily Dosing of Oral CR845

Systemic Exposure in Patients with Moderate CKD With Once-Daily Dosing of Oral CR845

Data for oral dosing (tablet strengths of 0.25 mg 0.5 mg and 1.0 mg) represent the arithmetic mean +- SEM. Mean exposure (AUC) in hemodialysis patients (HD) is normalized to an equivalent 24-hour interval.

Cara Therapeutics, Inc.
Format

JPEG

Source

Cara Therapeutics, Inc.

Downloads